title: Antecedents and consequences of drug abuse in rats selectively bred for high and low response to novelty.
abstract: Human genetic and epidemiological studies provide evidence that only a subset of individuals who experiment with potentially addictive drugs become addicts. What renders some individuals susceptible to addiction remains to be determined, but most would agree that there is no single trait underlying the disorder. However, there is evidence in humans that addiction liability has a genetic component, and that certain personality characteristics related to temperament (e.g. the sensation-seeking trait) are associated with individual differences in addiction liability. Consequently, we have used a selective breeding strategy based on locomotor response to a novel environment to generate two lines of rats with distinct behavioral characteristics. We have found that the resulting phenotypes differ on a number of neurobehavioral dimensions relevant to addiction. Relative to bred low-responder (bLR) rats, bred high-responder (bHR) rats exhibit increased exploratory behavior, are more impulsive, more aggressive, seek stimuli associated with rewards, and show a greater tendency to relapse. We therefore utilize this unique animal model to parse the genetic, neural and environmental factors that contribute to addiction liability. Our work shows that the glucocorticoid receptor (GR), dopaminergic molecules, and members of the fibroblast growth factor family are among the neurotransmitters and neuromodulators that play a role in both the initial susceptibility to addiction as well as the altered neural responses that follow chronic drug exposure. Moreover, our findings suggest that the hippocampus plays a major role in mediating vulnerability to addiction. It is hoped that this work will emphasize the importance of personalized treatment strategies and identify novel therapeutic targets for humans suffering from addictive disorders. This article is part of a Special Issue entitled 'NIDA 40th Anniversary Issue'.
authors: Molecular and Behavioral Neuroscience Institute, University of Michigan, 205 Zina Pitcher Place, Ann Arbor, MI 48109, USA; Department of Psychiatry, University of Michigan, Ann Arbor, MI, USA; Neuroscience Program, University of Michigan, Ann Arbor, MI, USA; Department of Psychology, University of Michigan, Ann Arbor, MI, USA. Electronic address: sflagel@umich.edu.
authors: Shelly B
authors: SB
authors: Flagel
authors: Maria
authors: M
authors: Waselus
authors: Sarah M
authors: SM
authors: Clinton
authors: Stanley J
authors: SJ
authors: Watson
authors: Huda
authors: H
authors: Akil
mesh_terms: D000818:Animals; D004195:Disease Models, Animal; D005106:Exploratory Behavior / Q000502:physiology*; D006801:Humans; D018782:Maze Learning / Q000502:physiology; D010551:Personality / Q000235:genetics*; D051381:Rats; D019966:Substance-Related Disorders / Q000235:genetics* / Q000523:psychology*
keywords: Addiction; Cocaine; Dopamine; Fibroblast growth factor (FGF); High-responder; Low-responder; Novelty-seeking; Selectively bred
references: Arch Gen Psychiatry. 2004 Sep;61(9):922-8
references: 15351771
references: Neuropsychopharmacology. 2011 Feb;36(3):569-79
references: 20980989
references: Behav Res Ther. 1970 Aug;8(3):249-66
references: 5470377
references: Curr Opin Psychiatry. 2007 May;20(3):255-61
references: 17415079
references: Behav Neurosci. 2005 Aug;119(4):1144-51
references: 16187844
references: Curr Top Behav Neurosci. 2012;11:25-44
references: 22020537
references: Biol Psychiatry. 2010 Oct 15;68(8):770-3
references: 20678754
references: Physiol Behav. 2011 May 3;103(2):210-6
references: 21303678
references: Neuropharmacology. 2009;56 Suppl 1:139-48
references: 18619474
references: Science. 1987 Apr 24;236(4800):410-6
references: 2882604
references: Drug Alcohol Depend. 2008 Jan 1;92(1-3):69-78
references: 17997051
references: Psychoneuroendocrinology. 2008 Feb;33(2):162-77
references: 18077099
references: Brain Res Brain Res Rev. 2001 Oct;36(2-3):129-38
references: 11690609
references: Pharmacol Rev. 2013 Jan 23;65(1):255-90
references: 23343975
references: Proc Natl Acad Sci U S A. 1991 Mar 15;88(6):2088-92
references: 2006148
references: Psychopharmacology (Berl). 2002 Oct;163(3-4):362-80
references: 12373437
references: Pers Individ Dif. 1996 Aug;21(2):283-285
references: 26146428
references: Science. 2008 Jun 6;320(5881):1352-5
references: 18535246
references: Pharmacol Biochem Behav. 2008 Sep;90(3):331-8
references: 18445506
references: Psychiatr Genet. 2010 Oct;20(5):207-14
references: 20520587
references: Arch Gen Psychiatry. 1993 Dec;50(12):991-9
references: 8250685
references: Behav Pharmacol. 2007 Jul;18(4):297-302
references: 17551322
references: Eur J Neurosci. 2011 Jun;33(12):2274-87
references: 21507084
references: Eur Neuropsychopharmacol. 2008 Aug;18(8):551-6
references: 18284941
references: Neuropsychopharmacology. 2011 Jul;36(8):1668-76
references: 21471956
references: Neuron. 2012 Oct 4;76(1):160-74
references: 23040813
references: J Neurosci. 2009 May 13;29(19):6379-87
references: 19439615
references: J Neurosci. 2000 Jan 15;20(2):RC55
references: 10632621
references: Eur Neuropsychopharmacol. 2012 Aug;22(8):607-13
references: 22209364
references: Neuropsychopharmacology. 2010 Jan;35(2):388-400
references: 19794408
references: Psychopharmacology (Berl). 2002 Jul;162(3):333-8
references: 12122492
references: Behav Genet. 2006 Sep;36(5):697-712
references: 16502134
references: Psychopharmacology (Berl). 2001 Dec;158(4):382-7
references: 11797059
references: Psychoneuroendocrinology. 2012 Feb;37(2):256-69
references: 21775066
references: Psychol Rev. 1984 Apr;91(2):251-68
references: 6571424
references: Synapse. 2007 May;61(5):263-7
references: 17318886
references: Neuropsychobiology. 1996;34(3):136-45
references: 8916071
references: Drug Alcohol Depend. 2012 Jun;123 Suppl 1:S59-71
references: 22342427
references: Science. 1998 Oct 9;282(5387):298-300
references: 9765157
references: Arch Gen Psychiatry. 1997 Jan;54(1):62-8
references: 9006402
references: Brain. 2011 Jul;134(Pt 7):2013-24
references: 21690575
references: Psychopharmacology (Berl). 2008 Sep;200(1):1-26
references: 18600315
references: J Neurosci. 2010 Jan 6;30(1):304-15
references: 20053911
references: Psychoneuroendocrinology. 1982;7(2-3):217-21
references: 7178375
references: Psychol Sci. 2006 Jun;17(6):478-84
references: 16771797
references: Mol Psychiatry. 2005 Apr;10(4):336-44
references: 15583701
references: Psychiatr Dev. 1986 Autumn;4(3):167-226
references: 3809156
references: Prog Neuropsychopharmacol Biol Psychiatry. 1994 Oct;18(6):1027-35
references: 7824757
references: Biol Psychiatry. 2004 Sep 1;56(5):308-16
references: 15336512
references: J Neurochem. 2006 Feb;96(4):996-1004
references: 16412094
references: Proc Natl Acad Sci U S A. 2005 Mar 1;102(9):3513-8
references: 15716360
references: Neuron. 2011 May 26;70(4):582-8
references: 21609817
references: Hippocampus. 2011 Jan;21(1):72-80
references: 20020436
references: Neuroscience. 2006 Feb;137(3):727-35
references: 16338078
references: J Neurosci. 2000 Jun 1;20(11):4226-32
references: 10818158
references: Neuropsychopharmacology. 2004 Jun;29(6):1190-202
references: 15010698
references: Proc Natl Acad Sci U S A. 2004 Aug 10;101(32):11851-6
references: 15280545
references: Anim Behav. 1968 Feb;16(1):92-6
references: 5639909
references: Curr Psychiatry Rep. 2012 Apr;14(2):150-8
references: 22367454
references: Proc Natl Acad Sci U S A. 1993 Dec 15;90(24):11738-42
references: 8265619
references: Psychopharmacology (Berl). 2007 Apr;191(3):679-88
references: 17136400
references: NIDA Res Monogr. 1996;163:277-99
references: 8809864
references: Biol Psychiatry. 2009 Oct 15;66(8):801-3
references: 19539267
references: Exp Clin Psychopharmacol. 2005 Nov;13(4):367-75
references: 16366767
references: Biol Psychiatry. 2012 Feb 1;71(3):224-31
references: 21872848
references: Nat Neurosci. 2012 Dec;15(12):1613-20
references: 23187693
references: Behav Brain Res. 2004 Aug 12;153(1):7-14
references: 15219701
references: Pharmacol Biochem Behav. 2009 Mar;92(1):100-4
references: 19014962
references: Science. 1989 Sep 29;245(4925):1511-3
references: 2781295
references: Nat Neurosci. 2006 Aug;9(8):1050-6
references: 16829955
references: Neuropsychopharmacology. 2009 Apr;34(5):1123-34
references: 18580876
references: PLoS Med. 2008 Jul 1;5(7):e141
references: 18597549
references: Q J Exp Psychol (Hove). 2006 Apr;59(4):625-53
references: 16707354
references: Behav Brain Res. 2011 Oct 1;223(2):255-61
references: 21507334
references: Brain Res. 1992 Aug 7;587(2):306-12
references: 1525663
references: Biol Psychiatry. 2009 May 15;65(10):869-73
references: 18930184
references: Biol Psychiatry. 2010 Apr 15;67(8):730-6
references: 20045508
references: Eur J Neurosci. 2010 Jan;31(1):79-89
references: 20104651
references: Brain Res. 2011 Oct 24;1419:34-45
references: 21925645
references: J Neurosci. 1994 Oct;14(10):6144-52
references: 7931568
references: J Pers Soc Psychol. 2000 Nov;79(5):776-92
references: 11079241
references: Subst Use Misuse. 2003 Jan;38(1):67-83
references: 12602807
references: Nature. 2011 Jan 6;469(7328):53-7
references: 21150898
references: Front Hum Neurosci. 2011 Nov 17;5:144
references: 22125521
references: Behav Pharmacol. 2001 Jul;12(4):267-75
references: 11548112
references: J Abnorm Child Psychol. 1994 Apr;22(2):177-203
references: 8064028
references: Psychopharmacology (Berl). 2001 Nov;158(2):175-80
references: 11702091
references: Cold Spring Harb Perspect Med. 2012 Nov 01;2(11):
references: 23125204
references: Neurosci Lett. 2008 Dec 3;446(2-3):105-7
references: 18824081
references: J Neurosci. 2000 Sep 15;20(18):6983-8
references: 10995843
references: Neurosci Biobehav Rev. 2005 Feb;29(1):83-97
references: 15652257
references: Science. 2007 Mar 2;315(5816):1267-70
references: 17332411
references: Biol Psychiatry. 2013 Jul 15;74(2):137-44
references: 23273722
references: Psychopharmacology (Berl). 2001 Aug;157(1):31-9
references: 11512040
references: Psychopharmacology (Berl). 1999 Oct;146(4):348-61
references: 10550486
references: Am J Addict. 1998 Summer;7(3):221-30
references: 9702290
references: Am J Psychiatry. 2012 Sep;169(9):926-36
references: 22952072
references: Biol Sex Differ. 2011 Mar 11;2:3
references: 21396095
references: Science. 2004 Aug 13;305(5686):1014-7
references: 15310906
references: Proc Natl Acad Sci U S A. 2004 Oct 26;101(43):15506-11
references: 15483108
references: Behav Pharmacol. 1995 Apr;6(3):229-237
references: 11224331
references: J Pers. 2000 Dec;68(6):999-1029
references: 11130742
references: Brain Res Bull. 1999 Apr;48(6):595-602
references: 10386839
references: Psychopharmacology (Berl). 2008 Apr;197(2):309-18
references: 18080114
references: Pharmacol Biochem Behav. 2012 Nov;103(1):6-17
references: 22819969
references: J Neurosci. 2008 Mar 5;28(10):2516-26
references: 18322096
references: Synapse. 1993 Jun;14(2):169-77
references: 8101394
references: Neurosci Biobehav Rev. 1996 Autumn;20(3):505-35
references: 8880737
references: J Neurosci. 2000 Dec 1;20(23):8876-85
references: 11102497
references: J Neurosci Res. 2003 Oct 1;74(1):74-80
references: 13130508
references: Physiol Behav. 1997 May;61(5):755-61
references: 9145948
references: J Affect Disord. 2009 Jun;115(3):367-75
references: 19004504
references: Biol Psychiatry. 2009 May 15;65(10):863-8
references: 18639867
references: Brain Res Brain Res Rev. 1993 Sep-Dec;18(3):247-91
references: 8401595
references: Neuroscience. 2011 Jun 2;183:81-9
references: 21453756
references: Neuropeptides. 2008 Jun;42(3):245-53
references: 18410964
references: Eur J Neurosci. 2011 Sep;34(6):994-1005
references: 21864320
references: Proc Natl Acad Sci U S A. 2011 May 10;108(19):8021-5
references: 21518861
references: Int J Pers Cent Med. 2012 Jun;2(2):240-249
references: 23243492
references: J Neurosci. 1998 Nov 15;18(22):9547-55
references: 9801391
references: Br J Psychiatry. 2005 Mar;186:190-6
references: 15738498